Losartan and ibuprofen
Pro Research Analysisby 
Searched over 200M research papers
Losartan and Ibuprofen: Effects, Metabolism, and Environmental Impact
In Utero Exposure to Losartan and Ibuprofen: Potential Toxicities
Research has highlighted significant concerns regarding the in utero exposure to losartan and ibuprofen. A retrospective study involving 124 children exposed to maternal medication revealed that four children developed serious conditions such as Alport syndrome, hearing impairment, kidney stones, and horseshoe kidney. These conditions were linked to the mothers' use of losartan for hypertension and ibuprofen as an NSAID during pregnancy. Specifically, one child developed Alport syndrome following exposure to losartan, while the other three conditions were associated with ibuprofen exposure .
Metabolism of Losartan and Ibuprofen: Role of CYP2C9 Genetic Variants
The metabolism of losartan and ibuprofen is significantly influenced by the cytochrome P450 (CYP) enzyme system, particularly the CYP2C9 enzyme. This enzyme metabolizes up to 20% of clinical drugs, including losartan and ibuprofen. Genetic variants of CYP2C9, such as CYP2C92 and CYP2C93, exhibit reduced catalytic activity compared to the wild-type enzyme. Structural studies of the CYP2C9*2 variant in complex with losartan have shown notable differences in drug binding and metabolism. These differences are due to altered conformations of secondary structural elements and residue side chains, which affect the enzyme's hydroxylation activity .
Environmental Presence of Losartan and Ibuprofen: Detection in Water Sources
The environmental impact of losartan and ibuprofen has been studied through the screening of wastewater and surface waters. In a study conducted in Bogotá, Colombia, both drugs and their metabolites were frequently detected in urban wastewater and surface waters. The study utilized advanced mass spectrometry techniques to identify these compounds, highlighting the widespread presence of pharmaceutical contaminants in the aquatic environment. This underscores the need for targeted methodologies to accurately quantify these contaminants and assess their environmental impact .
Conclusion
The research underscores the potential risks associated with the use of losartan and ibuprofen, particularly during pregnancy, and highlights the importance of understanding genetic variations in drug metabolism. Additionally, the environmental presence of these drugs calls for improved monitoring and regulatory measures to mitigate their impact on public health and ecosystems.
Sources and full results
Most relevant research papers on this topic